SemBioSys Genetics Inc. was a development stage agricultural biotechnology company. It utilized its patented safflower pharming platform to develop and make proteins and oils for the nutraceutical, functional food and beverage, and pharmaceutical industries. A University of Calgary spin-off (1994), SemBioSys became a publicly traded firm. Investors had included Bay City Capital, the Business Development Bank of Canada, Dow AgroSciences (a Canadian subsidiary of The Dow Chemical Company), Royal Bank Ventures Inc. (now RBC Capital Partners), the University of Calgary, Ventures West Capital Ltd., and Dr. Maurice Moloney. In May 2012, SemBioSys terminated its operations. More information...
According to PR-model, sembiosys.com is ranked 1,490,131st in multilingual Wikipedia, in particular this website is ranked 81,126th in Portuguese Wikipedia.
The website is placed before vivev.de and after aaviv.com in the BestRef global ranking of the most important sources of Wikipedia.
